Naïma Tafzi

Quantitative impact of pre‐analytical process on plasma uracil when testing for dihydropyrimidine dehydrogenase deficiency

Maud Maillard, Manon Launay, Bernard Royer et al. · British Journal of Clinical Pharmacology · 2022 · 25 citations · Full text

Pharmacy, Pharmacology, Biopharmaceutics +12

Phenotyping of Uracil and 5-Fluorouracil Metabolism Using LC-MS/MS for Prevention of Toxicity and Dose Adjustment of Fluoropyrimidines

Naïma Tafzi, Jean‐Baptiste Woillard, Aurélie Fleytoux et al. · Therapeutic Drug Monitoring · 2020 · 22 citations

Medicine, Pharmacokinetics, Pharmacology +16

Automatic quantification of uracil and dihydrouracil in plasma

Tiphaine Robin, Franck Saint‐Marcoux, Doriane Toinon et al. · Journal of Chromatography B · 2020 · 21 citations · Full text

Pharmacy, Biochemistry, Pharmacology +2

New perspectives for the therapeutic drug monitoring of tacrolimus: Quantification in volumetric DBS based on an automated extraction and LC-MS/MS analysis

Gauthier Rosé, Naïma Tafzi, Souleiman El Balkhi et al. · Journal of Chromatography B · 2023 · 15 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Acute visual loss following dapsone-induced methemoglobinemia and hemolysis

Delphine Hanuschk, Alexandra Kozyreff, Naïma Tafzi et al. · Clinical Toxicology · 2015 · 12 citations

Medicine, Ophthalmology, Pharmacology +13